Drug Type Chemical drugs |
Synonyms hydroxyl dendrimer therapeutics(Ashvattha Therapeutics LLC) |
Target |
Mechanism FXR agonists(Bile acid receptor FXR agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Ashvattha Therapeutics IncStartup |
Active Organization- |
Inactive Organization Ashvattha Therapeutics IncStartup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Cancer | Preclinical | US | Ashvattha Therapeutics IncStartup | 22 May 2021 |
Plexiform Neurofibroma | Preclinical | US | Ashvattha Therapeutics IncStartup | 22 May 2021 |
Inflammation | Preclinical | US | Ashvattha Therapeutics IncStartup | 31 Oct 2020 |